Bracket, with nine offices and more than 700 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs. Learn more about Bracket at www.bracketglobal.com.
Deloitte Advisory helps clients manage strategic, financial, operational, technological, and regulatory risk to enhance enterprise value, while our experience in mergers and acquisitions, fraud, litigation, and reorganizations helps clients emerge stronger and more resilient.
GLG’s mission is to transform the way top professionals share expertise and learn. We curate custom learning experiences with professionals and thought leaders around the world. GLG organizes conversations, small group meetings, mentorships, surveys and other interactions with a membership of more than 375,000 experts and thought leaders. Technology-driven and nimble, our 900 employees work in 21 offices around the globe. GLG is the world’s largest membership for professional learning. For more information visit www.glg.it/life-sciences.
Haug Partners is a full-service, national law firm that provides integrated multidisciplinary legal services for life science and technology companies. Our service offerings include: (i) Antitrust Litigation and Counseling; (ii) Commercial Litigation and Strategic Counseling; (iii) Due Diligence; (iv) FDA Compliance and Counseling; (v) Intellectual Property Enforcement; (vi) Intellectual Property Procurement and Strategy; (vii) International Trade Commission; (viii) Investigations, Compliance, and Risk Mitigation Services; (ix) Licensing and Transactions; and (x) Trademarks and Unfair Competition. With offices in New York, Washington, D.C., and Boston, and through working partnerships with firms in Germany, China, and Japan, Haug Partners has the resources, technical expertise, legal acumen, and business judgment to consistently deliver optimal outcomes for clients. The firm was founded in 1997 as Frommer Lawrence and Haug and adopted the Haug Partners name in March 2017.
ICON is a global provider of outsourced drug development services to biopharma, medical device, government, biosimilar and generic organisations. We offer a full range of clinical, consulting and commercial services that range from trial design to full study execution, and from clinical to post-market commercialisation. Our services are supported by in-depth therapeutic and regulatory expertise and market-leading technology and analytics. We are the only full service CRO that offers the knowledge, software and systems for adaptive trials.
INC Research (Nasdaq: INCR) is a leading global contract research organization (“CRO”), providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was named “Best Contract Research Organization” in December 2015 by an independent panel for Scrip Intelligence, and ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents, and experience spanning more than 110 countries.
inSeption’s insistence upon securing the “right” people to integrate into a true partnership alliance with its clients eliminates the vulnerability so often felt by operational leaders faced with evaluating traditional outsourcing options. inSeption’s core competency of identifying and securing the most experienced and proficient professionals builds the crucial foundation of a successful drug development program. Actively collaborating with its clients to custom design, hand select and assemble high-performing project teams empowers inSeption to tailor its services specifically to meet the needs of their programs. The inSeption model provides increased control, full transparency of project deliverables and timelines, and significant operational and cost efficiencies.
L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. We are uncompromising in our approach to helping clients consistently make better decisions, deliver improved business performance and create greater shareholder returns. The firm advises and supports global companies that are leaders in their industries — including the largest private and public sector organizations, private equity firms and emerging entrepreneurial businesses. Founded more than 30 years ago, L.E.K. employs more than 1,200 professionals across the Americas, Asia-Pacific, and Europe. For more information, go to www.lek.com.
NCGS, Incorporated is an international full-service CRO, providing clinical development support to pharmaceutical, biotechnology, medical device and diagnostic companies. NCGS’ business model is discernibly different from the industry standard: Utilizing highly tenured staff, NCGS consistently delivers studies on time, within budget and of the highest quality. NCGS is a WBENC-certified diversity supplier, has been in operation for more than 30 years, and supported the approval or expanded labeling of 34 products with zero 483s.
NCGS understands that the CRO-Sponsor relationship is one of shared vision, complementary expertise and trust. NCGS’ team understands the demands of the life science industries, seeking ways to make each clinical effort more quality-based, thorough, timely and cost-effective.
NCGS’ mission is to protect research subjects, capture quality data and maintain the integrity of science with the same passion one would protect their own domain. Each staff member is charged to function under the mantras, “This product could easily be used on your parent, sibling or yourself.” and “It is not only our hope for this product, it is the world’s hope for this product.”
UBC is a leading provider of pharmaceutical support services, partnering with life science companies to make medicine and medical products safer and more accessible. Our diverse suite of services helps bridge the gap between development and delivery and builds brand loyalty through patient access and adherence. UBC is well-known for our ability to generate authoritative, real-world evidence of product effectiveness, safety and value to assist healthcare decisions and enhance patient care.
WilmerHale is recognized internationally for its representation of life sciences companies and investors. We have significant capabilities and experience in mergers and acquisitions, venture capital financings, public offerings, and strategic collaboration and licensing transactions. We prepare and prosecute patents, defend clients’ innovations and assert their rights in critical patent litigation, and represent clients in regulatory matters. WilmerHale has 1,000 lawyers in 12 cities across the United States, Europe and Asia. Learn more at www.wilmerhale.com.